TENAX THERAPEUTICS INC (TENX) Stock Balance Sheet
NASDAQ:TENX • US88032L6056
Current stock price
14.45 USD
+0.97 (+7.2%)
At close:
14.45 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 97.56M | 94.85M | 9.79M | 2.12M | 5.58M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 6.66M | 1.83M | 1.89M | 1.08M | 105.00K | |||
| Total Current Assets | 104.23M | 96.69M | 11.68M | 3.21M | 5.69M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 0.00 | 187.00K | 295.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | 0.00 | 1.00K | 10.00K | 8.00K | |||
| Total Non-Current Assets | 0.00 | 0.00 | 1.00K | 197.00K | 303.00K | |||
| TOTAL ASSETS | 104.23M | 96.69M | 11.69M | 3.40M | 5.99M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 501.00K | 624.00K | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.11M | 1.54M | 1.01M | 775.00K | 704.00K | |||
| Accounts Payable | 6.04M | 3.16M | 2.07M | 448.00K | 860.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 7.16M | 4.69M | 3.59M | 1.85M | 1.56M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 64.00K | 184.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 64.00K | 184.00K | |||
| TOTAL LIABILITIES | 7.16M | 4.69M | 3.59M | 1.91M | 1.75M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -367.45M | -314.86M | -297.25M | -289.54M | -278.49M | |||
| Additional Paid In Capital | 464.52M | 406.85M | 305.35M | 291.03M | 282.74M | |||
| Common Shares | 1.00K | 300.00 | 0.00 | 5.00K | 3.00K | |||
| Other Shareholders' Equity | N/A | -300.00 | N/A | N/A | 0.00 | |||
| Shares Outstanding | 9.31M | 3.42M | 298.00K | 29.00K | 16.00K | |||
| Tangible Book Value per Share | 10.42 | 26.89 | 27.17 | 51.48 | 265.31 | |||
| Total Shareholders' Equity | 97.07M | 91.99M | 8.10M | 1.49M | 4.25M | |||
| TOTAL LIABILITIES AND EQUITY | 104.23M | 96.69M | 11.69M | 3.40M | 5.99M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 14.56 | 20.60 | 3.26 | 1.74 | 3.64 | |||
| Return On Assets (ROA) | -50.47% | -18.21% | -65.99% | -324.46% | -550.47% | |||
| Return On Equity (ROE) | -54.19% | -19.13% | -95.22% | -739.98% | -777.01% | |||
All data in USD , ROIC based on taxRate of 0.21